Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies - PubMed (original) (raw)
Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies
B Aylward et al. Bull World Health Organ. 1995.
Abstract
The unsafe use and disposal of injection equipment continues to put patients, health care workers, and the general community at risk of infections such as hepatitis B virus and human immunodeficiency virus. Although the potential for unsafe injection practices varies substantially with the type of equipment that is used, technology alone cannot totally eliminate the risk. A knowledge of the cost, practicality and, most importantly, the potential for misuse, is critical for selecting the most appropriate injection equipment for each immunization setting. Four types of injection equipment are currently available for administering vaccines: sterilizable needles and syringes; standard disposable needles and syringes; autodestruct needles and syringes; and jet injectors. In general, the cost per injection is lowest with sterilizable equipment and highest with autodestruct. However, only autodestruct syringes virtually eliminate the risk of unsafe injection practices. Owing to differences in cost and programme factors, in some settings it may be appropriate to use a combination of equipment. For example, autodestruct syringes may be used in areas where it is difficult to ensure adequate supervision, while in medium-sized, fixed-site clinics with safe injection practices, sterilizable equipment will be the most cost-effective.
PIP: Every year, more than 550 million injections are administered in developing countries through the Expanded Program on Immunization. It is imperative that great care be given to providing these immunizations with only sterile injection equipment. Otherwise, children may be subjected during immunization to infections such as hepatitis B virus and HIV. Sterilizable needles and syringes, standard disposable needles and syringes, autodestruct needles and syringes, and jet injectors are currently available for administering vaccines. The design and operation of the former two types of needles and syringes are, by definition, evident. The design of autodestruct needles and syringes and jet injectors, however, is less directly apparent from their nomenclature. Autodestruct syringes have a device in the barrel which prevents the plunger from being redrawn after a single use, thereby automatically blocking the syringe and preventing it from being reused. Jet injectors deliver immunizations with a high pressure jet of fluid generated by either a hydraulic or mechanical compression system. This equipment was developed for high workload use and has been employed in immunization campaigns for many years. Low workload injectors are being developed for use in the small immunization clinic setting. In general, the cost per injection is lowest with sterilizable equipment and highest with the autodestruct device. Only autodestruct syringes, however, virtually eliminate the risk of unsafe injection practices. It must be emphasized that technology alone cannot eliminate the risk of accidental infection using unsterile injection equipment. The authors note that it may be appropriate in some settings to use a combination of equipment. For example, autodestruct syringes may be used in areas where it is difficult to ensure adequate supervision, while in medium-sized, fixed-site clinics with safe injection practices, sterilizable equipment will be the most cost-effective.
Similar articles
- Sterilizable syringes: excessive risk or cost-effective option?
Battersby A, Feilden R, Nelson C. Battersby A, et al. Bull World Health Organ. 1999;77(10):812-9. Bull World Health Organ. 1999. PMID: 10593029 Free PMC article. Review. - [Cost of tetanus toxoid injection using a jet-injector (Imule) in collective immunization in Senegal: comparison with injection using a syringe and resterilizable needle].
Schlumberger M, Châtelet IP, Lafarge H, Genêt A, Gaye AB, Monnereau A, Sanou C, Diawara L, Gueye Y, Lang J. Schlumberger M, et al. Sante. 1999 Sep-Oct;9(5):319-26. Sante. 1999. PMID: 10657777 French. - Safety, effectiveness and ease of use of a non-reusable syringe in a developing country immunization programme.
Steinglass R, Boyd D, Grabowsky M, Laghari AG, Khan MA, Qavi A, Evans P. Steinglass R, et al. Bull World Health Organ. 1995;73(1):57-63. Bull World Health Organ. 1995. PMID: 7704926 Free PMC article. - Unsafe injections.
Kane M. Kane M. Bull World Health Organ. 1998;76(1):99-100. Bull World Health Organ. 1998. PMID: 9615502 Free PMC article. - The cost of unsafe injections.
Miller MA, Pisani E. Miller MA, et al. Bull World Health Organ. 1999;77(10):808-11. Bull World Health Organ. 1999. PMID: 10593028 Free PMC article. Review.
Cited by
- Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan.
Akhtar S, Younus M, Adil S, Hassan F, Jafri SH. Akhtar S, et al. BMC Gastroenterol. 2005 Aug 8;5:26. doi: 10.1186/1471-230X-5-26. BMC Gastroenterol. 2005. PMID: 16086833 Free PMC article. - Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.
Scharton-Kersten T, Yu Jm, Vassell R, O'Hagan D, Alving CR, Glenn GM. Scharton-Kersten T, et al. Infect Immun. 2000 Sep;68(9):5306-13. doi: 10.1128/IAI.68.9.5306-5313.2000. Infect Immun. 2000. PMID: 10948159 Free PMC article. - Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.
Glenn GM, Scharton-Kersten T, Vassell R, Matyas GR, Alving CR. Glenn GM, et al. Infect Immun. 1999 Mar;67(3):1100-6. doi: 10.1128/IAI.67.3.1100-1106.1999. Infect Immun. 1999. PMID: 10024549 Free PMC article. - Knowledge and Self-Reported Practice of Insulin Injection Device Disposal among Diabetes Patients in Gondar Town, Ethiopia: A Cross-Sectional Study.
Basazn Mekuria A, Melaku Gebresillassie B, Asfaw Erku D, Taye Haile K, Melese Birru E. Basazn Mekuria A, et al. J Diabetes Res. 2016;2016:1897517. doi: 10.1155/2016/1897517. Epub 2016 Sep 25. J Diabetes Res. 2016. PMID: 27738637 Free PMC article. - Should measles be eradicated?
Cutts FT, Steinglass R. Cutts FT, et al. BMJ. 1998 Mar 7;316(7133):765-7. doi: 10.1136/bmj.316.7133.765. BMJ. 1998. PMID: 9529417 Free PMC article. Review. No abstract available.
References
- J Am Med Assoc. 1955 Feb 19;157(8):633-7 - PubMed
- Trans R Soc Trop Med Hyg. 1989 Jan-Feb;83(1):106 - PubMed
- Trop Doct. 1989 Jul;19(3):124-6 - PubMed
- JAMA. 1989 May 12;261(18):2677-84 - PubMed
- Lancet. 1988 Jan 23;1(8578):189 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical